Diatta Thierno, Blazejewski Sylvie, Portier Arnaud, Lignot Séverine, Quesnot Ariane, Moore Nicholas, Fourrier-Réglat Annie
Université Victor Segalen, Pharmacology Department, 33076 Bordeaux, France.
Fundam Clin Pharmacol. 2007 Aug;21(4):371-8. doi: 10.1111/j.1472-8206.2007.00492.x.
Studies describing atypical antipsychotics when compared with conventional antipsychotic drugs are few in France. This study aimed to describe the frequency and characteristics of atypical antipsychotic prescribing. A cross-sectional national survey was conducted from February to June 2003 in a random sample of 100 volunteer French psychiatrists practicing in public psychiatric medical centers. Each psychiatrist was asked to complete a questionnaire for patients to whom at least one antipsychotic was prescribed during the period of the survey. The characteristics of the patients treated with atypical antipsychotics were identified with a logistic regression model. A total of 1733 patients were included in the study. The main diagnoses were schizophrenia (46.1%) and other psychoses (40.8%), followed by mood disorders (10%) and other psychiatric disorders (2.5%). Among these patients, 56% had at least one prescription of an atypical antipsychotic, 42.1% at least one conventional antipsychotic with immediate action and 29.9% at least one conventional antipsychotic with delayed action. Seventy percent of patients were treated with single-drug atypical antipsychotics. Compared with conventional antipsychotics with immediate action, atypical antipsychotics were less likely to be prescribed to patients over 35 years of age [odds ratio (OR) 0.4; 95% confidence interval (CI) 0.3-0.6], with duration of illness >10 years (OR 0.5; 95% CI 0.3-0.7), and were less likely to be used with concomitant corrector agents for neurological side effects (OR 0.4; 95% CI 0.3-0.6). This study shows the important use of atypical antipsychotic drugs especially in schizophrenic patients and younger patients.
在法国,与传统抗精神病药物相比,描述非典型抗精神病药物的研究较少。本研究旨在描述非典型抗精神病药物处方的频率和特征。2003年2月至6月,对在公共精神科医疗中心执业的100名法国志愿精神科医生进行了随机抽样的全国横断面调查。要求每位精神科医生为在调查期间至少开具过一种抗精神病药物的患者填写一份问卷。采用逻辑回归模型确定接受非典型抗精神病药物治疗患者的特征。共有1733名患者纳入研究。主要诊断为精神分裂症(46.1%)和其他精神病(40.8%),其次是情绪障碍(10%)和其他精神障碍(2.5%)。在这些患者中,56%至少有一次非典型抗精神病药物处方,42.1%至少有一次速效传统抗精神病药物处方,29.9%至少有一次长效传统抗精神病药物处方。70%的患者接受单药非典型抗精神病药物治疗。与速效传统抗精神病药物相比,非典型抗精神病药物较少开给35岁以上患者[比值比(OR)0.4;95%置信区间(CI)0.3 - 0.6]、病程>10年的患者(OR 0.5;95%CI 0.3 - 0.7),且较少与用于治疗神经副作用的校正剂联合使用(OR 0.4;95%CI 0.3 - 0.6)。本研究表明非典型抗精神病药物的重要用途,尤其是在精神分裂症患者和年轻患者中。